Inclusion of Patients with Severe Mental Illness in Clinical Trials: Issues and Recommendations Surrounding Informed Consent

Author： Welie Sander P.K.   Berghmans Ron L.P.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.1, 2006-01, pp. : 67-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Informed Consent and Antipsychotic Use in Patients with Schizophrenia: Issues and Recommendations

By Laugharne J.  

CNS Drugs, Vol. 9, Iss. 1, 1998-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials

By  

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 21-33

Bentham Science Publishers

Access to resources Recommend Favorite

Informed Consent and Informed Refusal

By WAGNER RICHARD F.   TORRES ABEL   PROPER STEVEN  

Dermatologic Surgery, Vol. 21, Iss. 6, 1995-06 ,pp. : 555-559

Elsevier

Access to resources Recommend Favorite

The Long-Term Relationships Between the Motivation for Change and Alcohol Use Severity Among Patients with Severe and Persistent Mental Illness

By Zhang Amy Y.   Harmon Julie A.   Werkner Janet   McCormick Richard A.  

Journal of Addictive Diseases, Vol. 25, Iss. 1, 2006-03 ,pp. : 121-128

Haworth Press

Access to resources Recommend Favorite

CONSORT recommendations for reporting harms in clinical trials

By  

Reactions Weekly, Vol. 1, Iss. 1031, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite